Mirae Asset Global Etfs Holdings Ltd. Precigen, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Precigen, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 82,085 shares of PGEN stock, worth $271,701. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,085
Previous 81,610
0.58%
Holding current value
$271,701
Previous $121,000
4.13%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PGEN
# of Institutions
164Shares Held
166MCall Options Held
511KPut Options Held
1M-
Third Security, LLC83.5MShares$276 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD16.3MShares$53.8 Million1.22% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.3MShares$37.3 Million0.03% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$33.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.07MShares$30 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $689M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...